Assess the clinical disease-modifying effects of one peptide test item given twice-weekly for 3 weeks relative to sham control and vehicle in the relapsing-remitting experimental autoimmune encephalom (2022–2024)

Grant type:
Argenica Therapeutics Limited
Researchers:
  • Emeritus Professor
    School of Biomedical Sciences
    Faculty of Medicine
  • Senior Research Officer
    School of Biomedical Sciences
    Faculty of Medicine
    Senior Research Officer
    School of Biomedical Sciences
    Faculty of Medicine
Funded by:
Argenica Therapeutics Limited